NCT02634788View on ClinicalTrials.gov

Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

January 29, 2016

Primary Completion Date

June 24, 2016

Study Completion Date

June 24, 2016

Conditions
Pain
Interventions
DRUG

Buprenorphine

Buprenorphine sublingual spray delivered via single 100 μL spray

DRUG

Placebo

Placebo-matching buprenorphine sublingual spray delivered via single 100 μL spray

Trial Locations (4)

21122

Chesapeake Research Group, Pasadena

84124

Jean Brown Research, Salt Lake City

85023

Arizona Research Center, Phoenix

92801

Anaheim Clinical Trials, Anaheim

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY

NCT02634788 - Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain | Biotech Hunter | Biotech Hunter